Found: 17
Select item for more details and to access through your institution.
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 192, n. 1, p. 153, doi. 10.1007/s10549-021-06475-2
- By:
- Publication type:
- Article
"Enjoy glass of wine before eating:" a randomized trial to test the orexigenic effects of this advice in advanced cancer patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 178, doi. 10.1016/j.cllc.2020.10.015
- By:
- Publication type:
- Article
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920910913
- By:
- Publication type:
- Article
DeImplementing Ineffective and Low-Value Clinical Practices: Research and Practice Opportunities in Community Oncology Settings.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 2, p. 1, doi. 10.1093/jncics/pkab020
- By:
- Publication type:
- Article
Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States.
- Published in:
- Journal of Public Health (09431853), 2010, v. 18, n. 1, p. 59, doi. 10.1007/s10389-009-0277-2
- By:
- Publication type:
- Article
Results of combined‐modality therapy for limited‐stage small cell lung carcinoma in the elderlyAdditional participating institutions include the following: Duluth CCOP, Duluth, MN (Daniel A. Nikcevich, M.D.); Cedar Rapids Oncology Project CCOP, Cedar Rapids, IA (Martin Wiesenfeld, M.D.); Meritcare Hospital CCOP, Fargo, ND (Ralph Levitt, M.D.); Toledo Community Hospital Oncology Program CCOP, Toledo, OH (Paul L. Schaefer, M.D.); Sioux Community Cancer Consortium, Sioux Falls, SD (Loren K. Tschetter, M.D.); Geisinger Clinical Oncology Program, Danville, PA (Suresh Nair, M.D.); Rapid City Regional Oncology Group, Rapid City, SD (Larry P. Ebbert, M.D.); Saskatoon Cancer Center, Saskatoon, Saskatchewan, Canada and Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (Muhammad Salim, M.D.); Scottsdale CCOP, Scottsdale, AZ (Tom R. Fitch, M.D.); Carle Cancer Center CCOP, Urbana, IL (Kendrith M. Rowland, M.D.); Medcenter One Health Systems, Bismarck, ND (Ferdinand Addo, M.D.); Altru Health S
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 11, p. 2349, doi. 10.1002/cncr.21034
- By:
- Publication type:
- Article
Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: Results from Intergroup Trial N9741.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 10, p. 2170
- By:
- Publication type:
- Article
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma.
- Published in:
- 2000
- By:
- Publication type:
- journal article
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222.
- Published in:
- Cancer Management & Research, 2009, v. 1, p. 61
- By:
- Publication type:
- Article
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701).
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 15, p. 2343, doi. 10.1002/cncr.28714
- By:
- Publication type:
- Article
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial.
- Published in:
- Oncologist, 2022, v. 27, n. 4, p. 292, doi. 10.1093/oncolo/oyab025
- By:
- Publication type:
- Article
Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 16, p. 1230, doi. 10.1093/jnci/djt181
- By:
- Publication type:
- Article